as on September 13, 2025 at 1:29 am IST
Day's High
1.88%
Upside
52 Week's Low
52 Week's High
21.07%
Downside
46.32%
Upside
Check Mimedx Group, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.0B
EPS (TTM)
0.325
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.50%
PE Ratio (TTM)
33.05
Industry PE ratio
-3.773885542168675
P/B Ratio
33.0476
PEG Ratio
2.97
EBITDA
53.7M
Revenue (TTM)
363.8M
Profit Margin
8.84%
Return On Equity TTM
16.61%
Track how Mimedx Group, Inc. P/E has moved over time to understand its valuation trends.
Mimedx Group, Inc. in the last 5 years
Lowest (11.83x)
September 30, 2024
Industry (-3.77x)
September 13, 2025
Today (33.05x)
September 13, 2025
Highest (28.81x)
March 31, 2025
Today’s Price to Earnings Ratio: 33.05x
Compare market cap, revenue, PE, and other key metrics of Mimedx Group, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.0B | NA | 33.05 | 8.84% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Mimedx Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mimedx Group, Inc. investment value today
Current value as on today
₹1,16,554
Returns
₹16,554
(+16.55%)
Returns from Mimedx Group, Inc. Stock
₹11,415 (+11.41%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Mimedx Group, Inc.. Average target price of $12.2
Get share price movements and forecasts by analysts on Mimedx Group, Inc..
What analysts predicted
43.2%UPSIDE
Target Price
$12.2
Current Price
$6.93
Analyzed by
11 Analysts
Target
$12.20
Mimedx Group, Inc. target price $12.2, a slight upside of 43.2% compared to current price of $6.93. According to 11 analysts rating.
Search interest for Mimedx Group, Inc. Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 88.20M → 98.60M (in $), with an average increase of 10.6% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 7.02M → 9.61M (in $), with an average increase of 27.0% per quarter
Price Rise
In the last 3 years, MDXG stock has moved up by 100.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 23.1%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 64.1%
Organisation | Mimedx Group, Inc. |
Headquarters | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
Industry | Biotechnology |
CEO | Mr. Joseph H. Capper |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Mark P. Graves | Senior VP & Chief Compliance Officer |
Ms. Kate Surdez | Chief Human Resources Officer |
Dr. David H. Mason Jr., M.D. | Chief Medical Officer |
Mr. Joseph H. Capper | CEO & Director |
Mr. Douglas C. Rice CPA | Chief Financial Officer |
Ms. Ricci S. Whitlow | Executive VP & COO |
Mr. William F. Hulse IV | General Counsel & Chief Administrative Officer |
Mr. Matthew M. Notarianni | Head of Investor Relations |
Ms. Kimberly Maersk-Moller | Chief Commercial Officer |
Ms. Hilary Dixon | Vice President of Investor Relations & Corporate Strategic Communications |
Mimedx Group, Inc. share price today is $6.93 as on at the close of the market. Mimedx Group, Inc. share today touched a day high of $7.06 and a low of $6.93.
Mimedx Group, Inc. share touched a 52 week high of $10.14 on and a 52 week low of $5.47 on . Mimedx Group, Inc. stock price today i.e. is closed at $6.93,which is 31.66% down from its 52 week high and 26.69% up from its 52 week low.
Mimedx Group, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Mimedx Group, Inc. (MDXG) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Mimedx Group, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mimedx Group, Inc. share’s latest price of $6.93 as on September 13, 2025 at 1:29 am IST, you will get 1.4430 shares of Mimedx Group, Inc.. Learn more about
fractional shares .